106 Views
Monday Poster Session
Category: Esophagus
Amrit K. Kamboj, MD
Mayo Clinic
Rochester, MN, United States
Patients with esophageal graft versus host disease (GVHD) (n=43) | |
Clinical characteristics | |
Median (range) age | 59.3 (4.7-75.2) years |
Gender Men Women | 29 (67.4%) 14 (32.6%) |
Caucasian race | 43 (100%) |
Median (range) body mass index | 26.7 (16.4-50.4) kg/m2 |
Tobacco use None Former Current | 24 (55.8%) 18 (41.9%) 1 (2.3%) |
Alcohol use None Former Current | 36 (83.7%) 3 (7.0%) 4 (9.3%) |
History of transplantation Hematopoietic stem cell transplant Liver transplant | 42 (97.7%) 1 (2.3%) |
Received prophylaxis for GVHD | 42 (97.7%) |
Median (range) time from transplantation to development of esophageal GVHD | 3 (0-39) months |
Known GVHD prior to esophageal GVHD Skin Liver Mouth/eyes Lung | 25 (58.1%) 24 (55.8%) 7 (16.3%) 6 (14.0%) 2 (4.7%) |
Other organ involvement at esophageal GVHD diagnosis Skin Liver Mouth/eyes | 31 (72.1%) 17 (39.5%) 17 (39.5%) |
GVHD chronicity at esophageal GVHD diagnosis Acute Chronic | 27 (62.8%) 16 (37.2%) |
GVHD severity at esophageal GVHD diagnosis Mild Moderate Severity | 18 (41.9%) 6 (14.0%) 19 (44.2%) |